Aaron Wealth Advisors LLC Buys Shares of 4,342 ICU Medical, Inc. $ICUI

Aaron Wealth Advisors LLC bought a new stake in ICU Medical, Inc. (NASDAQ:ICUI) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,342 shares of the medical instruments supplier’s stock, valued at approximately $521,000.

Several other large investors have also recently made changes to their positions in the company. Cullen Frost Bankers Inc. acquired a new position in ICU Medical in the 2nd quarter valued at $38,000. Blue Trust Inc. boosted its stake in ICU Medical by 17.6% during the 2nd quarter. Blue Trust Inc. now owns 942 shares of the medical instruments supplier’s stock worth $124,000 after purchasing an additional 141 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of ICU Medical by 11.6% during the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 101 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of ICU Medical in the second quarter valued at about $177,000. Finally, AlphaQuest LLC raised its position in shares of ICU Medical by 3,058.3% in the second quarter. AlphaQuest LLC now owns 1,516 shares of the medical instruments supplier’s stock valued at $200,000 after buying an additional 1,468 shares during the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Trading Down 0.1%

ICUI opened at $146.17 on Friday. ICU Medical, Inc. has a one year low of $107.00 and a one year high of $175.51. The stock has a market capitalization of $3.61 billion, a PE ratio of -471.50 and a beta of 0.82. The business’s 50 day moving average price is $134.23 and its 200 day moving average price is $129.78. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.19 and a current ratio of 2.45.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, November 6th. The medical instruments supplier reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.43 by $0.60. ICU Medical had a positive return on equity of 7.71% and a negative net margin of 0.32%.The company had revenue of $533.30 million during the quarter, compared to analysts’ expectations of $511.46 million. During the same quarter last year, the firm earned $1.59 earnings per share. The firm’s quarterly revenue was down 8.9% compared to the same quarter last year. ICU Medical has set its FY 2025 guidance at 7.350-7.650 EPS. As a group, equities research analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

ICUI has been the topic of a number of recent research reports. Piper Sandler boosted their price target on shares of ICU Medical from $153.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a research note on Wednesday, October 8th. Wall Street Zen cut ICU Medical from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Finally, KeyCorp increased their price target on ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a report on Friday, November 7th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, ICU Medical has a consensus rating of “Moderate Buy” and an average price target of $175.67.

Insider Transactions at ICU Medical

In related news, Director Elisha W. Finney sold 1,285 shares of the business’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $140.42, for a total value of $180,439.70. Following the sale, the director directly owned 3,995 shares in the company, valued at approximately $560,977.90. The trade was a 24.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Virginia Ruth Sanzone sold 930 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $142.34, for a total transaction of $132,376.20. Following the completion of the transaction, the vice president directly owned 5,456 shares in the company, valued at $776,607.04. The trade was a 14.56% decrease in their position. The SEC filing for this sale provides additional information. 1.50% of the stock is currently owned by company insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.